Study of Safety & Efficacy of the Combination of LJM716 & BYL719 in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC)
Clinical trial NCT01822613 · COMPLETED
Trial details
- NCT number
- NCT01822613
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-26
- Primary completion
- 2016-06-03
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.